Editas Medicine (EDIT) to Present New Data Showing Advancements for Translating CRISPR Technologies into … – StreetInsider.com
|
Editas Medicine (EDIT) to Present New Data Showing Advancements for Translating CRISPR Technologies into …
StreetInsider.com “Editas Medicine is at the forefront of the rapidly-advancing science that is unlocking the potential of CRISPR for patients,” said Katrine Bosley, President and Chief Executive Officer, Editas Medicine. “These data at ASGCT showcase advances towards … |
